Endogenex

📍 PLYMOUTH, United States🗓 Founded 2017👥 23 employees💰 Last funded Apr 2021
Endogenex is a clinical stage company focused on improving outcomes and quality of life for patients living with Type 2 Diabetes (T2D). Endogenex has developed a novel therapy that utilizes pulsed electric fields to promote regeneration of the duodenal mucosa for improvement in glycemic control in patients with T2D.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2017
Founded
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Endogenex?
Endogenex has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Endogenex last raise funding?
The most recent investment in Endogenex recorded on gritt.io was in April 2021.
When was Endogenex founded?
Endogenex was founded in 2017.
What industry is Endogenex in?
Endogenex operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Endogenex based?
Endogenex is headquartered in PLYMOUTH, United States.